Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology

E Schrezenmeier, T Dörner - Nature Reviews Rheumatology, 2020 - nature.com
Despite widespread clinical use of antimalarial drugs such as hydroxychloroquine and
chloroquine in the treatment of rheumatoid arthritis (RA), systemic lupus erythematosus …

Toll-like receptor signalling in B cells during systemic lupus erythematosus

S Fillatreau, B Manfroi, T Dörner - Nature Reviews Rheumatology, 2021 - nature.com
B lymphocytes have a central role in autoimmune diseases, which are often defined by
specific autoantibody patterns and feature a loss of B cell tolerance. A prototypic disease …

SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4

F Onodi, L Bonnet-Madin, L Meertens, L Karpf… - Journal of Experimental …, 2021 - rupress.org
Several studies have analyzed antiviral immune pathways in late-stage severe COVID-19.
However, the initial steps of SARS-CoV-2 antiviral immunity are poorly understood. Here we …

The therapeutic landscape of rheumatoid arthritis: current state and future directions

S Shams, JM Martinez, JRD Dawson, J Flores… - Frontiers in …, 2021 - frontiersin.org
Rheumatoid arthritis (RA) is a debilitating autoimmune disease with grave physical,
emotional and socioeconomic consequences. Despite advances in targeted biologic and …

Dendritic cells in systemic lupus erythematosus: from pathogenesis to therapeutic applications

J Liu, X Zhang, X Cao - Journal of Autoimmunity, 2022 - Elsevier
Systemic lupus erythematosus (SLE) is a severe chronic systemic autoimmune disease
caused by complicated interactions among genetic, epigenetic, and immunological factors …

IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies

J Bennett, DT Starczynowski - Current Opinion in Hematology, 2022 - journals.lww.com
IRAK-targeted therapies that have matriculated to early phase trials are yielding promising
preliminary results. However, studies of IRAK kinase signaling continue to defy conventional …

Advances in the pathogenesis and treatment of systemic lupus erythematosus

D Accapezzato, R Caccavale, MP Paroli… - International journal of …, 2023 - mdpi.com
Systemic lupus erythematosus (SLE) is a genetically predisposed, female-predominant
disease, characterized by multiple organ damage, that in its most severe forms can be life …

Toll-like receptors 7 and 9 regulate the proliferation and differentiation of B cells in systemic lupus erythematosus

L Wen, B Zhang, X Wu, R Liu, H Fan, L Han… - Frontiers in …, 2023 - frontiersin.org
Systemic lupus erythematosus (SLE) is an autoimmune illness marked by the loss of
immune tolerance and the production of autoantibodies against nucleic acids and other …

Long noncoding RNA IRL regulates NF-κB-mediated immune responses through suppression of miR-27c-3p-dependent IRAK4 downregulation in teleost fish

W Zheng, Q Chu, T Xu - Journal of Biological Chemistry, 2021 - ASBMB
Growing pieces of evidence show that the long noncoding RNAs (lncRNAs) as new
regulators participate in the regulation of various physiological and pathological processes …

Natural killer cells in inflammatory autoimmune diseases

Y Yang, J Day… - Clinical & …, 2021 - Wiley Online Library
Natural killer (NK) cells are a specialised population of innate lymphoid cells (ILCs) that help
control local immune responses. Through natural cytotoxicity, production of cytokines and …